Bayer’s BlueRock inks cardiovascular cell therapy delivery deal | Fierce Pharma
Bayer’s BlueRock Therapeutics has partnered with BioCardia on the delivery of cell therapies, paying a “sizable” upfront fee to access minimally … Read source
Click to rate this post!
[Total: 0 Average: 0]